BSE Live
Oct 09, 09:58Prev. Close
5492.20
Open Price
5527.50
Bid Price (Qty.)
5489.10 (1)
Offer Price (Qty.)
5499.00 (6)
NSE Live
Oct 09, 09:58Prev. Close
5493.50
Open Price
5520.00
Bid Price (Qty.)
5493.50 (2)
Offer Price (Qty.)
5495.00 (6)
Profit & Loss account of Alkem Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 8,191.96 | 7,265.85 | 6,323.57 | 5,781.21 | 4,988.55 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 9.33 | 164.97 | 0.00 | |
Revenue From Operations [Net] | 8,191.96 | 7,265.85 | 6,314.24 | 5,616.24 | 4,988.55 | |
Total Operating Revenues | 8,344.36 | 7,357.19 | 6,421.85 | 5,687.53 | 5,047.93 | |
Other Income | 104.22 | 87.70 | 95.95 | 112.01 | 239.71 | |
Total Revenue | 8,448.58 | 7,444.89 | 6,517.80 | 5,799.54 | 5,287.64 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 2,131.83 | 1,811.14 | 1,567.23 | 1,449.32 | 1,173.33 | |
Purchase Of Stock-In Trade | 1,443.06 | 1,130.19 | 1,035.89 | 1,061.81 | 894.99 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FGWIP And Stock In Trade | -229.95 | 3.64 | -90.22 | -289.60 | -104.44 | |
Employee Benefit Expenses | 1,505.49 | 1,362.46 | 1,191.64 | 1,003.85 | 861.08 | |
Finance Costs | 65.06 | 54.63 | 55.33 | 45.16 | 71.24 | |
Depreciation And Amortisation Expenses | 252.76 | 193.18 | 143.03 | 101.17 | 93.31 | |
Other Expenses | 2,020.54 | 1,934.99 | 1,688.92 | 1,463.20 | 1,369.72 | |
Total Expenses | 7,188.79 | 6,490.23 | 5,591.82 | 4,834.91 | 4,359.23 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,259.79 | 954.66 | 925.98 | 964.63 | 928.41 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 1,259.79 | 954.66 | 925.98 | 964.63 | 928.41 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 354.25 | 229.17 | 242.52 | 245.28 | 217.96 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -212.39 | -48.15 | 45.04 | -185.32 | -41.78 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 110.48 | 181.02 | 287.56 | 59.96 | 176.18 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1,149.31 | 773.64 | 638.42 | 904.67 | 752.23 | |
Profit/Loss From Continuing Operations | 1,149.31 | 773.64 | 638.42 | 904.67 | 752.23 | |
Profit/Loss For The Period | 1,149.31 | 773.64 | 638.42 | 904.67 | 752.23 | |
Minority Interest | -22.24 | -13.13 | -7.48 | -12.64 | -10.64 | |
Consolidated Profit/Loss After MI And Associates | 1,127.07 | 760.51 | 630.94 | 892.03 | 741.59 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 94.00 | 64.00 | 53.00 | 75.00 | 62.00 | |
Diluted EPS (Rs.) | 94.00 | 64.00 | 53.00 | 75.00 | 62.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 358.70 | 179.35 | 179.35 | 71.74 | 151.84 | |
Tax On Dividend | 74.38 | 37.28 | 37.02 | 14.60 | 31.10 |
29.09.2025
23.09.2025
19.09.2025
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.06.2025
Alkem Lab Standalone March 2025 Net Sales at Rs 2,044.94 crore, down 13.55% Y-o-Y
05.06.2025
Alkem Lab Consolidated March 2025 Net Sales at Rs 3,143.75 crore, up 7.08% Y-o-Y
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key